Top Markets
#1 Wrapped One Wrapped One +14,737.38%
#2 Wrapped STX (Velar) Wrapped STX (Velar) +2,972.21%
#3 Black Phoenix Black Phoenix +335.79%
#4 aPriori aPriori +181.23%
#5 Bedrock Bedrock +79.53%
#6 Cysic Cysic +51.82%
#7 Prom Prom +46.77%
#8 Playnance Playnance +34.93%
#9 Bitway Bitway +27.53%
#10 COTI COTI +26.22%
Coin of the day
Wrapped One Wrapped One
Instellingen
Taal
DUTCH
Valuta
USD
Thema
Pharnext S.A. Pharnext S.A.

Pharnext S.A.

ALPHA
Rang in aandelen #42432
Based in France, Pharnext SA is a clinical-stage biopharmaceutical firm... Based in France, Pharnext SA is a clinical-stage biopharmaceutical firm dedicated to creating treatments for a range of neurodegenerative disorders, encompassing both rare (orphan) and common forms. Its pipeline features SYNGILITY, which has advanced through Phase III trials for Charcot-Marie-Tooth disease type 1A (CMT1A). Additionally, PXT864 has concluded Phase II clinical studies for Alzheimer's disease, and is also being explored for its potential in Parkinson's disease and amyotrophic lateral sclerosis (ALS). Pharnext also innovates with PLEOTHERAPY, a proprietary platform that harnesses big genetic data and artificial intelligence. In a collaborative effort, the company holds an agreement with the University Hospital Institute Mediterranee Infection to assess existing pharmaceuticals for their potential application against the COVID-19 virus. The organization was established in 2007, with its main offices located in Issy-Les-Moulineaux, France.
Aandeelprijs
$0.00023723
Laatst gesynchroniseerd: 2024-08-26
Marktkapitalisatie
$1.41K
Verandering (1 dag)
111.67%
Verandering (1 jaar)
0.00%
Land
FR
Handel Pharnext S.A. (ALPHA)

Categorie

Healthcare
P/B-ratio voor Pharnext S.A. (ALPHA)
P/B-ratio op August 2026 TTM: 0.00
Volgens de meest recente financiële rapporten en aandelenkoers van Pharnext S.A. is de huidige P/B-ratio (TTM) 0.00. Eind 2022 had het bedrijf een P/B-ratio van -303.89M.
P/B-ratiohistoriek voor Pharnext S.A. van 2012 tot 2026
P/B-ratio aan het einde van elk jaar
Jaar P/B-ratio Wijzigen
2026 (TTM) 0.00 -100.00%
2023 -0.02 -100.00%
2022 -303.89M -100.00%
2021 -18.548T -96.18%
2020 -485.040T -66.25%
2019 -1.44Qa 95.99%
2018 -733.358T -44.70%
2017 -1.33Qa -129.61%
2016 4.48Qa -660.02%
2015 -799.743T -45.58%
2014 -1.47Qa -64.17%
2013 -4.10Qa 0.00%
2012 0.00 0.00%
P/B-ratio voor vergelijkbare bedrijven of concurrenten
Bedrijf P/B-ratio Verschil in P/B-ratio Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.2613 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.3483 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 3.634 -
BE
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR